Cytokinetics (CYTK) Prepaid Assets (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Prepaid Assets of $13.9 million for Q1 2026, down 11.94% year-over-year from $15.8 million in Q1 2025, and down 17.99% quarter-over-quarter from $17.0 million in Q4 2025.
Cytokinetics (CYTK) Prepaid Assets (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Prepaid Assets for 17 consecutive years, with $13.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 11.94% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $13.9 million (down 11.94% YoY), while the FY2025 annual figure was $17.0 million, up 11.22% from the prior year.
- Prepaid Assets declined to $13.9 million in Q1 2026 per CYTK's latest filing, from $17.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $20.0 million in Q2 2025 and bottomed at $6.7 million in Q3 2024.
- Historically, Prepaid Assets has averaged $14.6 million across 5 years, with a median of $14.3 million in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 180.77% — and 2024, when it tumbled 66.13%.
- Cytokinetics' Prepaid Assets stood at $12.5 million in 2022, then slipped by 4.16% to $11.9 million in 2023, then grew by 27.9% to $15.3 million in 2024, then grew by 11.22% to $17.0 million in 2025, then decreased by 17.99% to $13.9 million in 2026.
- Business Quant data shows CYTK's Prepaid Assets at $13.9 million in Q1 2026, $17.0 million in Q4 2025, and $13.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.99 Mn |
| Mar 31, 2026 | 13.93 Mn |
| Dec 31, 2025 | 16.99 Mn |
| Sep 30, 2025 | 13.01 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Mar 31, 2025 | 15.82 Mn |
| Dec 31, 2024 | 15.28 Mn |
| Sep 30, 2024 | 6.67 Mn |
| Jun 30, 2024 | 11.04 Mn |
| Mar 31, 2024 | 18.91 Mn |
| Dec 31, 2023 | 11.94 Mn |
| Sep 30, 2023 | 19.68 Mn |
| Jun 30, 2023 | 19.87 Mn |
| Mar 31, 2023 | 15.66 Mn |
| Dec 31, 2022 | 12.46 Mn |
| Sep 30, 2022 | 14.32 Mn |
| Jun 30, 2022 | 14.25 Mn |
| Mar 31, 2022 | 8.50 Mn |
| Dec 31, 2021 | 12.22 Mn |
| Sep 30, 2021 | 16.66 Mn |